CMA vs LYRA
CMA (CMA) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
CMA (CMA) common stock.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
CMA does not have a complete income-statement cache yet.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
LYRA currently screens at market cap $14.4M.
Not investment advice. Open the CMA and LYRA stock pages for the full models.
Not investment advice.